Patents by Inventor C. Blake Gilks

C. Blake Gilks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis of Gynecological Neoplasms By Detecting The Levels of Oviduct-Specific Glycoprotein
    Publication number: 20100190200
    Abstract: The present invention provides a method for detecting cancer in a patient. A sample from the patient is provided, and the level of oviduct-specific glycoprotein (OGP) in the sample is determined and compared to a control sample. Increased levels of OGP in the sample as compared to the control indicates that the patient has cancer. In one aspect, the cancer is a gynecological cancer, such as ovarian cancer. Kits for conducting the methods of the invention are also provided.
    Type: Application
    Filed: December 21, 2009
    Publication date: July 29, 2010
    Inventors: NELLY AUERSPERG, MICHELLE WOO, C. BLAKE GILKS
  • Diagnosis of Gynecological Neoplasms by Detecting the Levels of Oviduct-Specific Glycoprotein
    Publication number: 20090017461
    Abstract: The present invention provides a method for detecting cancer in a patient. A sample from the patient is provided, and the level of oviduct-specific glycoprotein (OGP) in the sample is determined and compared to a control sample. Increased levels of OGP in the sample as compared to the control indicates that the patient has cancer. In one aspect, the cancer is a gynecological cancer, such as ovarian cancer. Kits for conducting the methods of the invention are also provided.
    Type: Application
    Filed: June 24, 2008
    Publication date: January 15, 2009
    Inventors: NELLY AUERSPERG, MICHELLE WOO, C. BLAKE GILKS
  • Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein
    Patent number: 7407762
    Abstract: The present invention provides a method for detecting cancer in a patient. A sample from the patient is provided, and the level of oviduct-specific glycoprotein (OGP) in the sample is determined and compared to a control sample. Increased levels of OGP in the sample as compared to the control indicates that the patient has cancer. In one aspect, the cancer is a gynecological cancer, such as ovarian cancer. Kits for conducting the methods of the invention are also provided.
    Type: Grant
    Filed: March 11, 2004
    Date of Patent: August 5, 2008
    Assignee: The University of British Columbia
    Inventors: Nelly Auersperg, Michelle Woo, C. Blake Gilks